» Articles » PMID: 10531491

Purification, Solution Properties and Crystallization of SIV Integrase Containing a Continuous Core and C-terminal Domain

Overview
Specialty Chemistry
Date 1999 Oct 26
PMID 10531491
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

The C-terminal two-thirds segment of integrase derived from the simian immunodeficiency virus has been cloned, expressed in Escherichia coli, and purified to greater than 95% homogeneity. The protein encompasses amino-acid residues 50-293 and contains a F185H substitution to enhance solubility. In dilute solutions at concentrations below 1 mg ml(-1), the enzyme is predominantly dimeric. At the higher concentrations (>10 mg ml(-1)) required to enable crystallization, the enzyme self-associates to form species with molecular weights greater than 200 kDa. Despite the apparent high aggregation in solution, the enzyme crystallizes from a 8%(v/v) polyethylene glycol (molecular weight 6000) solution in a form suitable for X-ray diffraction studies. The resulting single crystals belong to the space group P2(1)2(1)2(1), with unit-cell parameters a = 79.76, b = 99.98, c = 150.2 A, alpha = beta = gamma = 90 degrees and Z = 4. Under X-ray irradiation generated with a rotating-anode generator, the crystals diffract to 2.8 A resolution and allow collection of a native 3 A resolution diffraction data set.

Citing Articles

Surface patches on recombinant erythropoietin predict protein solubility: engineering proteins to minimise aggregation.

Carballo-Amador M, Mckenzie E, Dickson A, Warwicker J BMC Biotechnol. 2019; 19(1):26.

PMID: 31072369 PMC: 6507049. DOI: 10.1186/s12896-019-0520-z.


Nonhuman Primates and Humanized Mice for Studies of HIV-1 Integrase Inhibitors: A Review.

Hassounah S, Mesplede T, Wainberg M Pathog Immun. 2019; 1(1):41-67.

PMID: 30993244 PMC: 6423640. DOI: 10.20411/pai.v1i1.104.


Characterization of the Drug Resistance Profiles of Integrase Strand Transfer Inhibitors in Simian Immunodeficiency Virus SIVmac239.

Hassounah S, Liu Y, Quashie P, Oliveira M, Moisi D, Brenner B J Virol. 2015; 89(23):12002-13.

PMID: 26378179 PMC: 4645305. DOI: 10.1128/JVI.02131-15.


Differential multimerization of Moloney murine leukemia virus integrase purified under nondenaturing conditions.

Villanueva R, Jonsson C, Jones J, Georgiadis M, Roth M Virology. 2003; 316(1):146-60.

PMID: 14599799 PMC: 5653259. DOI: 10.1016/s0042-6822(03)00559-2.


A directed approach to improving the solubility of Moloney murine leukemia virus reverse transcriptase.

Das D, Georgiadis M Protein Sci. 2001; 10(10):1936-41.

PMID: 11567084 PMC: 2374227. DOI: 10.1110/ps.16301.